NCT05692674View on ClinicalTrials.gov

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

PHASE2RecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Breast Cancer
Interventions
RADIATION

adjuvant hypofractionated intensity-modulated proton radiotherapy

CTV1: chest wall ± regional lymph drainage area, 40.05Gy (RBE) in 15 fractions with proton radiotherapy;

Trial Locations (1)

201321

RECRUITING

Shanghai Proton and Heavy Ion center, Shanghai

All Listed Sponsors
lead

Shanghai Proton and Heavy Ion Center

OTHER